The size of the Global Antiseptics and Disinfectants market is anticipated to grow at 6.77% CAGR from 2019 to 2024 and it is estimated that the global market was valued at USD 7.1 billion in 2019 and is expected to reach USD 9.9 billion by 2024.
Antiseptic is a chemical substance used to kill the pathogens and harmful microorganisms in or on the surface tissue of the human body. They mainly act by dissolving cell membranes, protein denaturation and cause dehydration of the cells due to evaporation. For instance, Chloroxylenol is a chlorinated phenolic antiseptic mostly active against gram-positive bacteria and is used in lubricating cream for vaginal examination. On the other hand, disinfectants are chemicals that are used to kill the pathogenic microorganism in or on the surface of objects. The disinfectant's main course of action includes the disruption of cell membranes and the denaturation of proteins and enzymes of the cell. These chemical agents are very effective against vegetative gram-positive and gram-negative bacteria, mycobacteria, and viruses. For instance, Lysol a phenol compound is used as a general disinfectant for domestic or hospital use like disinfection of floors, bathrooms, washbasins, organic waste such as sputum, feces, urine, etc.
Key Market Drivers
The global antiseptics and disinfectants market was expected to witness high growth over the forecast period due to the increasing percentage of hospitals and advanced healthcare facilities across the globe. In addition, the rising trend of the health club and fitness center is also expected to drive the antiseptics and disinfectants market. Moreover, the keen interest of the young generation towards precaution over the flu, bacterial and viral infections will probably increase the demand for antiseptics and disinfectants.
However, strict regulation and saturated market of developed economies are projected to hinder the market growth.
Potential Growth Opportunities
Some of the factors contributing to the Antiseptics and Disinfectants market growth are rising cases of HAIs due to lack of sanitation and prevention. For example, according to the Centres for Disease Control and Prevention (CDC), each year about one out of every 25 hospital patients suffers from at least one health-related infection. The demand for the drug is projected to increase in such situations. It is expected that policy efforts to reduce HAI cases and raise awareness of home and personal hygiene would create growth opportunities for market players. Increasing awareness, particularly in developing economies like the Asia Pacific, Middle East, and Africa, and Latin America, is expected to boost the market further in the near future.
Suitable reprocessing of medical devices and endoscopes is quite necessary because the infection can be spread from one patient to the next as these devices come into close contact with the skin and body. In hospitals, approaches are necessary to maintain sufficient hygiene and sanitation, thereby reducing the risk of HAIs. This trend is expected to fuel market growth throughout the forecast period for antiseptics and disinfectants.
Raising healthcare spending in developed and developing countries may boost the number of hospitals that are also projected to increase demand for antiseptics & disinfectants. For example, in recent years, according to Eurostat, Germany, France, and Sweden had the largest GDP healthcare spending. These very factors are also anticipated to propel the growth of the segment throughout the forecast period.
Recent Developments in the industry:
Market Size Available
2018 – 2024
2019 - 2024
By End User, Type & Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
Market Leaders Profiled
3M Company, Abc Compounding, Advanced Sterilization Products, American Biotech Labs, Angelini Pharma Inc., Becton, Dickinson And Company, Bio-Cide International Inc., Cardinal Health, Nufarm Limited and Carefusion Corp.
This research report on the Global Antiseptics and Disinfectants market has been segmented and sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.
Antiseptics and Disinfectants Market Analysis – By Type:
On the basis of type, the Alcohol and aldehydes segments accounted for the largest share of the market. Alcohols and aldehydes have the largest share of the market. In addition, together biguanides, amides, and quaternary ammonium compounds have the second largest market share. Growing keen interest in health care is another important driving factor that is expected to propel the antiseptic and disinfectant market.
Antiseptics and Disinfectants Market Analysis – By End-User:
On the basis of End User, the antiseptic and disinfectant market has been dominated by the institutional end-user segment. This growth is mainly attributed due to the presence of a large number of hospitals coupled with an increase in the number of medical professionals across the globe. Hospitals and healthcare segment is expected to register the highest growth in the coming years due to the outbreak of infectious diseases such as swine flu and avian flu which has triggered the use of antiseptics and disinfectants products market in developing countries. Domestic use of antiseptics and disinfectant is also anticipated to experience lucrative growth due to increasing public awareness regarding the potential dangers of microbial infection infections.
Antiseptics and Disinfectants Market Analysis – By Region:
Europe accounts for the major share of the global antiseptic and disinfectant market. The region is expected to witness growth on account of rising healthcare expenditure in Norway, Denmark, and other European countries. From the last decade, there is markedly increased in the domestic use of antiseptic and disinfectant in this region due to increasing awareness about pandemic diseases such as spreading flu and viral infections.
Asia Pacific is expected to witness the highest CAGR during the forecast period owing to the widespread of Ayurveda in this region. The growing number of the medical sector coupled along with literacy rate mainly in China, India, Indonesia, and Thailand is driving the antiseptic and disinfectant market in this region. In addition, raising awareness towards personal care and maintaining hygiene in emerging economies of China and India is expected to augment the market growth of antiseptics and the disinfectant market in this region in the near future.
North America is expected to witness moderate growth within the forecast period owing to the saturation of the red meat market in the U.S and Mexico on antiseptic and disinfectant. This is expected to have an adverse impact on the antiseptic and disinfectant market over the years. However, the demand for antiseptic and disinfectant has been increasing in the past few years owing to the rising awareness of the nutritional benefits of antiseptic and disinfectant. Major companies in the U.S. are expanding their vegetable production capacities to keep up with the growing demand for foreign imports in the US market. This is expected to fuel the market growth of the antiseptic and disinfectant market. In addition, a high literacy rate coupled with the increasing number of healthcare centers and business centers are likely to contribute to the growth of the antiseptic and disinfectant market.
List of key market participants profiled in this report
The Global Antiseptics and Disinfectants Market is dominated by companies like 3M Company, Abc Compounding, Advanced Sterilization Products, American Biotech Labs, Angelini Pharma Inc., Becton, Dickinson And Company, Bio-Cide International Inc., Cardinal Health, Nufarm Limited and Carefusion Corp.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 End User
5.1.2 Domestic User
5.1.3 Institutional User
5.1.4 Y-o-Y Growth Analysis, By End User
5.1.5 Market Attractiveness Analysis, By End User
5.1.6 Market Share Analysis, By End User
5.2.2 Alcohol and Aldehyde
5.2.3 Phenols and Derivatives
5.2.4 Biguanides and Amides
5.2.5 Quaternary Ammonium Compounds
5.2.6 Iodine Compounds
5.2.8 Y-o-Y Growth Analysis, By Type
5.2.9 Market Attractiveness Analysis, By Type
5.2.10 Market Share Analysis, By Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By End User
184.108.40.206 By Type
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By End User
22.214.171.124 By Type
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By End User
184.108.40.206 By Type
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 3M Company
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abc Compounding
8.3 Advanced Sterilization Products
8.4 American Biotech Labs
8.5 Angelini Pharma Inc.
8.6 Becton, Dickinson And Company
8.7 Bio-Cide International Inc.
8.8 ICardinal Health
8.9 Carefusion Corp.
8.10 Nufarm Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures